Phase 2b REZOLVE-AA Topline Results from 36-Week Induction Treatment Period (cc5087)
-2m
MRT-2359 Phase 1/2 Clinical Data Update
-1h 5m
Presentation for Investors – Basic information on Mabion
-1h 45m
-1h 54m
MHRA - Medicines and Healthcare products Regulatory Agency
Quarterly reports on the import of unlicensed medicines
-1h 57m
Initial Registration Statement (Form S-1)
-2h 51m
Initial Registration Statement (Form S-1)
-2h 54m
FDA - Food and Drug Administration
-15h 30m
Quarterly Report for Quarter Ending October 31, 2025 (Form 10-Q)
-15h 55m
AstraZeneca Pharmaceuticals LP
-16h 20m